| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,614 |
13,711 |
$468K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,565 |
7,918 |
$388K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,000 |
751 |
$60K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
846 |
659 |
$59K |
| 95886 |
|
695 |
582 |
$35K |
| 95911 |
|
279 |
235 |
$30K |
| 64483 |
|
348 |
217 |
$25K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
141 |
101 |
$19K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
135 |
90 |
$6K |
| L0648 |
Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf |
19 |
14 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
47 |
39 |
$3K |
| 99152 |
|
163 |
104 |
$3K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
281 |
197 |
$755.36 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
30 |
22 |
$677.60 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
26 |
14 |
$577.75 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
46 |
26 |
$502.31 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
48 |
26 |
$467.55 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
26 |
14 |
$390.44 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
2,442 |
1,830 |
$329.09 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
534 |
363 |
$216.04 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
22 |
12 |
$64.47 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
16 |
13 |
$60.11 |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
15 |
13 |
$26.92 |